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Objective: To evaluate the diagnostic accuracy of multidetector 64-slice computed tomography 
(MDCT) in the diagnosis and differentiation of benign and malignant ovarian masses using 
histopathology and surgical findings as the gold standard.
Material and methods: This study was conducted in Aga Khan University Hospital, 
Karachi, Pakistan. Data was reviewed retrospectively from 1 November 2008 to 12 December 
2009. One hundred patients found to have ovarian masses on CT scan were included in the 
study. CT scan was performed in all these patients after administration of oral and IV contrast. 
Ovarian masses were classified as benign and malignant on scan findings. Imaging findings 
were compared with histopathologic results and surgical findings. Sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of 
MDCT were calculated.
Results: MDCT was found to have 97% sensitivity, 91% specificity, and an accuracy of 96% 
in the differentiation of benign and malignant ovarian masses, while PPV and NPV were 97% 
and 91%, respectively.
Conclusion: MDCT imaging offers a safe, accurate and noninvasive modality to differentiate 
between benign and malignant ovarian masses.
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Introduction
Adnexal masses can be benign or malignant and the benign masses greatly outnumber 
malignant ones.1 Ovarian cancer is one of the most common gynecological malignancies 
and cause of death in the western world and the USA. It is also one of the most prevalent 
cancers in Pakistan.2,3 Precise characterization of an adnexal lesion is important as it 
dictates further management; hence, the role of radiology is very important. Until the 
last decade, exploratory laparotomy was used for the diagnosis and staging of adnexal 
masses, however, modern imaging techniques have demonstrated similar accuracy in 
the diagnosing and staging of ovarian carcinoma. Ultrasound is the first line modality 
to evaluate adnexal pathologies, however, most of the time it is unable to differentiate 
between benign and malignant lesions and the extent of disease in malignant cases. 
Sometimes when conventional ultrasound reveals complex morphology then other 
diagnostic tools can be used such as color Doppler and functional tumor vessel 
properties, serum CA 125 levels, nuclear magnetic resonance imaging, and in some 
cases laparoscopy.4 CT is the investigation of choice in planning further management 
in patients believed to have metastatic disease. Multidetector computed tomography 
(MDCT) also allows comprehensive evaluation of primary tumour and the site of International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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peritoneal metastasis and lymphadenopathy. On CT scan, 
masses can be characterized and features pertaining to 
benignity and malignancy can be observed. Local data 
regarding ovarian mass evaluation by MDCT are scarce. 
Therefore, the objective of this study was to evaluate the 
diagnostic accuracy of MDCT in our local population to 
differentiate between benign and malignant ovarian masses 
and to compare the findings with histopathologic results 
and surgery.
Material and methods
We retrospectively reviewed the preoperative MDCT 
findings of 100 ovarian tumors classified as either benign or 
malignant at subsequent surgical resection. Most patients 
had been referred for an asymptomatic adnexal mass. One 
had been referred because of pelvic pain, and two had been 
referred because of a previous ovarian cyst. The mean 
age of the patients was 50 ± 17 years with an age range 
from 19 to 82 years. Evaluators were blinded with surgical 
findings. We excluded patients with bilateral ovarian masses, 
concomitant carcinoma breast with metastatic disease, 
postoperative patients, those who were diagnosed as having 
malignant masses on ultrasound, and those in which origin 
from ovary was uncertain.
Patients were given oral nonionic contrast 2 hours before 
scanning. All scans were performed by MDCT on a 64 row CT 
scanner. The patients were scanned from the base of the lungs 
to the symphysis pubis after IV injection of 80–100 mL of 
nonionic contrast in portovenous phase with a scanning delay 
of 60–90s. Image slices of 10-mm-thickness were obtained 
followed by reconstruction in sagittal and coronal planes. 
MDCT images were reviewed by a consultant radiologist with 
experience in gynecological CT imaging. CT findings used 
to diagnose malignancy were: diameter greater than 4 cm, 
cystic-solid mass, necrosis in a solid lesion, cystic lesion with 
thick, irregular walls or septa, and/or with papillary projections 
(Figure 1). Presence of ascites, peritoneal metastases, 
and lymphadenopathy were used to confirm malignancy. 
In addition, the presence of omental cake, peritoneal 
deposits, mesenteric deposits, and lymphadenopathy were 
also documented. Benign lesions have diameters less than 
4 cm and well defined margins, without evidence of local or 
distant spread. Cystic lesions are unilocular, and have thin 
walls with minimal septations, and the absence of papillary 
projection. Statistical analysis was performed using SPSS 
(v.16; SPSS Inc; Chicago, IL). The sensitivity, specificity, 
positive predictive value (PPV), negative predictive value 
(NPV), and diagnostic accuracy were calculated.
Results
Out of the 100 ovarian lesions, 76 were read by MDCT as 
malignant and 24 as benign lesions. On later histopathological 
findings, 76 of the 100 lesions had malignant lesions while 
24 were benign. In the benign group, patients’ ages ranged 
from 19–82 years (mean, 23.5 years). In the malignant group, 
patients’ ages ranged from 48–72 years (mean, 60 years).
Malignant lesions included papillary carcinoma (n = 18), 
malignant mullerian tumor (n = 12), adenocarcinomas (n = 32), 
and endometrioid carcinomas (n = 14). Benign lesions were 
simple ovarian cyst (n = 2), corpus luteal cyst (n = 2), benign 
cystadenoma (n = 4), dermoid (n = 2), teratomas (n = 2), and 
endometriomas (n = 12) (See Tables 1 and 2).
Enhancing solid 
mass from right
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Figure 1 Fifty-year-old female presented with a palpable mass in the lower abdomen. 
Oral and IV contrast enhanced cT revealed 10 cm heterogeneously enhancing solid 
mass arising from right adnexa.
Table 1 Final diagnosis: benign lesions n = 24
Multidetector computed  
tomography findings
Histopathology/surgery   
findings
Thin walled cyst, less than 4 cm in size simple ovarian cyst n = 2
Thin walled cyst, less than 4 cm in size corpus luteal cyst n = 2
Thin walled cyst, less than 4 cm in size,  
except in one case which was a solid lesion  
of less than 4 cm in size with necrosis
Benign cystadenoma n = 4
Solid lesion, thick wall, calcifications Dermoid cyst n = 2
Thin walled cyst of less than 4 cm  
in size, few areas of hemorrhage
endometrioma n = 12
Solid well defined lesion, fat density,  
except one which had central necrosis  
and no fat density
Teratoma n = 2International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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There were two false positive cases: one on imaging 
appeared as a solid lesion with necrosis and an adherent 
fallopian tube; and the other one had an adjacent endometrioma 
deposit on the broad ligament which we mistakenly identified 
as a solid component. Both cases also had ascites as an 
ancillary finding.
Similarly there were two false negative results: one which 
we labeled as benign on the basis of its small size, ,4 cm, and 
well defined wall, which was an endometrioid carcinoma; and 
the other which we identified as a large simple cyst with thin 
septations was found to be a mucinous cyst adenocarcinoma 
via histopathology.
Thus, there were 74 true positives, 2 false positives, 
22 true negative, and 2 false negative results reported on 
MDCT based assessment. Overall, MDCT was found to have 
97.3% sensitivity, 91.6% specificity, and an accuracy of 96% 
in the differentiation of benign and malignant ovarian masses, 
while PPV and NPV were 97.3% and 91.6%, respectively.
Discussion
In day-to-day practice, we come across many cases of 
adnexal masses. Some of these turn out to be benign, some 
borderline, and some malignant. When an ovarian mass is 
detected, there are two major issues: to determine whether it 
is benign or malignant, and then if it is malignant, to look for 
the extent of disease.5,6 If the nature of the mass is adequately 
determined on the image, then it saves the patient unnecessary 
surgery and expense. Similarly if staging is accurately done 
on imaging, again it becomes cost-effective and it helps in 
further planning.7,8
However, we understand that surgery has a role in 
definite diagnosis and the further characterization of masses. 
Sometimes CT underestimates staging and pelvic examination 
by a gynecologist and serum CA-125 are of limited value in 
the diagnosis of pelvic masses and their sensitivity is often 
below 50%.8 The sensitivity of morphologic analysis with 
ultrasound in predicting malignancy in ovarian tumors has 
been shown to be 85%–97%, whereas its specificity ranges 
from 56%–95%.9–11
Our results are comparable to previously published 
international literature (Table 3).12–14 A meta-analysis conducted 
by Kinkel et al described that CT shows sensitivity and specificity 
of 81% and 87% respectively when used for indeterminate 
masses seen on ultrasound.12 Similarly, Liu  et al reported that 
PET/CT scanner shows a sensitivity of 87% and specificity 
of 100% for differentiating benign from malignant ovarian 
cancers.14 Tsili et al also described in their study that MDCT 
can categorize adnexal masses into benign and malignant in up 
to 93% and 89% of the cases.13 Our study reported a sensitivity 
and specificity of 97% and 91%, respectively.
CT appearances of ovarian masses vary widely and 
accurate histologic characterization is not always possible. 
Although tumor markers like CA-125, AFP, and HCG 
are indicative of ovarian cancer and germ cell tumors 
respectively, careful consideration inspite of the components 
of the masses and evidence of malignant spread are useful 
from a management aspect.15,16
Certain radiologic findings predominate for each type of 
tumor; knowledge of these key features of ovarian tumors 
may allow a specific diagnosis or substantial narrowing of 
differential diagnosis.17–19 The image appearance of ovarian 
tumors ranges from cystic to solid masses. Although tumors 
have similar clinical and radiological findings, predominant 
or specific key features are present in each type of ovarian 
tumor.20–22
Our study shows high accuracy (96%), however, there 
were two false positive and two false negative results. Lesions 
characterized as benign have imaging characteristics similar 
to benign lesions, ie, less than 4 cm in size, smooth walls 
without thick septations, making evaluation of these tumors 
difficult. Similarly, regarding false positive results, these 
lesions have characteristics of malignant lesions, ie, solid 
lesions with necrosis, infiltration to adjacent organs and 
Table 2 Final diagnosis: malignant lesions n = 76
Multidetector computed  
tomography findings
Histopathology/surgery  
findings
Thick walled, large solid cum  
cystic mass, ascites, lymphnodes
Papillary carcinoma n = 18
Thick walled, large masses with  
central necrosis
Malignant mullerian n = 12
Large multiseptated, solid cum cystic,  
ascites except one which was a large  
cyst with thin internal septations
Adenocarcinoma n = 32
Large solid masses, lymph nodes,  
omental thickening except one  
which was less than 4 cm and had  
well defined thin walls
endometriod carcinoma n = 14
Table  3  Sensitivity  and  specificity  of  multidetector  computed 
tomography  in  differentiating  benign  from  malignant  adnexal 
masses
Author Sensitivity (%) Specificity (%)
Kinkel et al12 81 87
Tsili et al13 90 88
Liu et al14 87 100
Mubarak et ala 97 91
Note: athe present study.International Journal of Women’s Health
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-womens-health-journal
The International Journal of Women’s Health is an international, peer-
reviewed open-access journal publishing original research, reports, 
reviews and commentaries on all aspects of women’s healthcare includ-
ing gynecology, obstetrics, and breast cancer. Subject areas include: 
Chronic conditions (migraine headaches, arthritis, osteoporosis); 
Endocrine and autoimmune syndromes; Sexual and reproductive 
health; Psychological and psychosocial conditions. The manuscript 
management system is completely online and includes a very quick 
and fair peer-review system. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
126
Mubarak et al
the presence of ascites. These features make it difficult to 
recognize on images, resulting in false positive and negative 
results. Other possibilities include interpretation error or not 
using reformatted images properly.
Our study has a few limitations besides the small number 
of benign cases included in the sample. Only those patients 
who were referred to MDCT scan were included, which 
introduces bias. No interobserver agreement for MDCT 
images evaluation was calculated.
Conclusion
MDCT is an excellent noninvasive modality to differentiate 
adnexal masses from benign and malignant causes, and the 
CT findings used to diagnose malignancy were: diameter 
greater than 4 cm, cystic-solid mass, necrosis in a solid 
lesion, cystic lesion with thick, irregular walls or septa, 
and/or with papillary projections. The presence of ascites, 
peritoneal metastases, and lymphadenopathy was also used 
to confirm malignancy.
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